ProCE Banner Activity

Clinical Evidence Using Pathologic Response as Clinical Trial Endpoint


Download this slideset from an AACR satellite symposium to learn about clinical evidence of pathologic response as clinical trial endpoint in early stage cancers.

Released: April 14, 2023



Patrick Forde

Patrick Forde, MBBCh

Director, Thoracic Oncology Research Program
Oncology Department
Johns Hopkins University
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb